Cargando…
Nanoparticulate carriers for the treatment of coronary restenosis
The current treatment for coronary restenosis following balloon angioplasty involves the use of a mechanical or a drug-eluting stent. Despite the high usage of commercially-available drug-eluting stents in the cardiac field, there are a number of limitations. This review will present the background...
Autores principales: | Brito, Luis, Amiji, Mansoor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673979/ https://www.ncbi.nlm.nih.gov/pubmed/17722543 |
Ejemplares similares
-
Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis
por: Brito, Luis A, et al.
Publicado: (2010) -
Nanoparticulate systems as drug carriers: the need
por: Patravale, Vandana, et al.
Publicado: (2012) -
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2009) -
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
por: Žigrayová, Dominika, et al.
Publicado: (2023) -
Coronary restenosis
Publicado: (1993)